On December 2, 2024, CVS Health Corporation, a Delaware corporation, made an official announcement through a press release regarding the initiation of cash tender offers. The offers are aimed at two categories of notes: the 4.100% Senior Notes due 2025, referred to as the “Any and All Notes”, and a maximum principal amount from a variety of series of notes. These include the 2.700% Senior Notes due 2040, the 3.875% Senior Notes due 2047 issued by the subsidiary Aetna Inc., and several other series. The total purchase amount for these notes is set at $2 billion, excluding accrued interest.
CVS Health expects to utilize the net proceeds gained from the issuance of subordinated debt securities, known as the New Notes, to finalize the Tender Offers post the announcement date. The company appointed Barclays Capital Inc. and Mizuho Securities USA LLC as Dealer Managers for the tender offers, with D.F. King & Co., Inc. acting as the Tender and Information Agent.
The Offers to Purchase, along with relevant details and guidelines for tendering, can be accessed online. The company is emphasizing that this press release is not to be considered as a solicitation for offers to purchase securities.
As a leading health solutions company, CVS Health is persistent in its vision to create a comprehensive world of health services for individuals, aligning care to meet diverse needs. The firm’s forward-looking statements emphasize that these actions are subject to uncertainties, underlining the importance of evaluating the Offer to Purchase diligently and seeking appropriate advice before exercising any tendering decisions.
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read CVS Health’s 8K filing here.
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Recommended Stories
- Five stocks we like better than CVS Health
- Investing in Commodities: What Are They? How to Invest in Them
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
- The Most Important Warren Buffett Stock for Investors: His Own
- 4 AI-Powered Fintechs Revolutionizing the Future of Finance
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Ambarella’s Traction Drives Stock Surge: Market Reversal Underway